Orthopediatrics Corp (NASDAQ:KIDS) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 2,320,000 shares, a growth of 37.3% from the August 31st total of 1,690,000 shares. Based on an average daily trading volume, of 152,900 shares, the days-to-cover ratio is presently 15.2 days. Currently, 17.1% of the shares of the stock are short sold.
Several brokerages have weighed in on KIDS. Needham & Company LLC upped their target price on shares of Orthopediatrics from $49.00 to $57.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. BidaskClub lowered shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research report on Wednesday, September 2nd. Stifel Nicolaus upped their target price on shares of Orthopediatrics from $48.00 to $55.00 in a research report on Tuesday, June 16th. BTIG Research increased their price target on shares of Orthopediatrics from $48.00 to $54.00 and gave the company a “buy” rating in a research report on Monday, June 8th. Finally, Zacks Investment Research lowered shares of Orthopediatrics from a “hold” rating to a “sell” rating in a research report on Thursday, August 13th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $52.29.
NASDAQ:KIDS traded up $0.50 during trading hours on Thursday, reaching $46.42. 138,604 shares of the company were exchanged, compared to its average volume of 140,114. The company has a debt-to-equity ratio of 0.09, a current ratio of 7.28 and a quick ratio of 5.31. The firm has a market cap of $897.69 million, a price-to-earnings ratio of -33.28 and a beta of 0.72. Orthopediatrics has a 52-week low of $32.21 and a 52-week high of $55.98. The stock has a 50 day simple moving average of $48.20 and a 200 day simple moving average of $44.68.
Large investors have recently bought and sold shares of the business. Ameritas Investment Partners Inc. raised its stake in Orthopediatrics by 31.7% during the second quarter. Ameritas Investment Partners Inc. now owns 1,056 shares of the company’s stock worth $46,000 after purchasing an additional 254 shares during the period. Great West Life Assurance Co. Can raised its stake in Orthopediatrics by 216.1% during the second quarter. Great West Life Assurance Co. Can now owns 1,078 shares of the company’s stock worth $47,000 after purchasing an additional 737 shares during the period. Parkside Financial Bank & Trust raised its stake in Orthopediatrics by 45.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,481 shares of the company’s stock worth $65,000 after purchasing an additional 464 shares during the period. BNP Paribas Arbitrage SA raised its stake in shares of Orthopediatrics by 133.4% in the 1st quarter. BNP Paribas Arbitrage SA now owns 3,050 shares of the company’s stock valued at $121,000 after acquiring an additional 1,743 shares during the period. Finally, Captrust Financial Advisors purchased a new position in shares of Orthopediatrics in the 2nd quarter valued at $136,000. 67.30% of the stock is currently owned by institutional investors.
Orthopediatrics Company Profile
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Featured Article: Pattern Day Trader – What is the PDT Rule?
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.